关于乐尔医疗

Royalyze Medical was established in Feb.2, 2007 in Guilin with registered capitalUSD 500 thousands, which intergrates R &D, manufacture of in vitro diagnostic products. It was awarded as an excellent enterprise in Guangxi medical device in dustry in 2016. The double parameters gout classification system was supported by science and technology innovation fund. Royalyze Medical focus on R &D of electrochemical biosensor detection technology It is the pioneer enterprise in China which master the core technology of enzyme electrode. Royalyze Medical has 100 thousand level clean workshop 525.6 m2, 10 thousand level clean area 30.5 m2. Since 2015, company has passed ISO13485 : 2013 quality system authentication and has got CE certificate of 12 kinds products, which enjoy great sales in Germany, Italy, Spain and other European Union countries. The patent product includes: The double parameters gout classification system, The double glucose monitoring system, The multi-monitoring system. Especially The Intelligent multi-monitoring system which combi-9 test in one meter, It requires only about 3 micro liter blood sample and 15 seconds for lipid profile test, it is the pioneer in the international market. With the accurate and fasting testing feature, It is suitable for the integration of disease prevention, health surveillance, old-age management and medical service under the condition of informationization, and greatly facilitates the use of clinicians at home and abroad. In order to promote the rapid electrochemical detection technology, Royalyze Medical has set up Royalyze Health Science and Technology Company in Shenzhen which is oriented to the domestic and international market. It undertakes the intelligent design of new technology and new products. It integrates the responsibility of network marketing, marketing and technical cooperation, while Royalyze Medical focuses on R&D and production.